Rozenberg O A, Mikhaĭlova N Ia, Dolgopiatova M A, Loshakova L V, Makar'eva N V
Farmakol Toksikol. 1988 Mar-Apr;51(2):92-4.
In experiments on mice, rats, rabbits and dogs it was found that liposome-incapsulated triombrast administered intravenously possesses specific properties of contrasting the liver and spleen. It accumulates predominantly in these organs and 80% of 125I-labeled triombrast is excreted within the first 24 hours, the rest amount is excreted within the first week. It was also shown that the drug conforms to safety standards of the Pharmacological Committee of the USSR Ministry of Health.
在对小鼠、大鼠、兔子和狗进行的实验中发现，静脉注射脂质体包裹的三溴沙仑具有使肝脏和脾脏显影的特殊性质。它主要在这些器官中蓄积，125I标记的三溴沙仑80%在最初24小时内排出，其余部分在第一周内排出。还表明该药物符合苏联卫生部药理委员会的安全标准。
